Boundless Bio, Common Stock Price Prediction
| BOLD Stock | USD 9.35 0.30 3.31% |
Oversold Vs Overbought
0
Oversold | Overbought |
Boundless Bio, Common stock price prediction is an act of determining the future value of Boundless Bio, shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Boundless Bio,'s future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Boundless Bio, and does not consider all of the tangible or intangible factors available from Boundless Bio,'s fundamental data. We analyze noise-free headlines and recent hype associated with Boundless Bio, Common, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Boundless Bio, based on different types of headlines from major news networks to social media. The Boundless stock price prediction module provides an analysis of price elasticity to changes in media outlook on Boundless Bio, over a specific investment horizon. Using Boundless Bio, hype-based prediction, you can estimate the value of Boundless Bio, Common from the perspective of Boundless Bio, response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Boundless Bio,. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Boundless Bio, to buy its stock at a price that has no basis in reality. In that case, they are not buying Boundless because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Boundless Bio, after-hype prediction price | USD 9.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Boundless |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Boundless Bio,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Boundless Bio, After-Hype Price Prediction Density Analysis
As far as predicting the price of Boundless Bio, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Boundless Bio, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Boundless Bio,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Boundless Bio, Estimiated After-Hype Price Volatility
In the context of predicting Boundless Bio,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Boundless Bio,'s historical news coverage. Boundless Bio,'s after-hype downside and upside margins for the prediction period are 3.93 and 14.17, respectively. We have considered Boundless Bio,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Boundless Bio, is slightly risky at this time. Analysis and calculation of next after-hype price of Boundless Bio, Common is based on 3 months time horizon.
Boundless Bio, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Boundless Bio, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Boundless Bio, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Boundless Bio,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.47 | 5.21 | 1.12 | 0.18 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
9.35 | 9.05 | 0.00 |
|
Boundless Bio, Hype Timeline
Boundless Bio, Common is currently traded for 9.35. The entity has historical hype elasticity of -1.12, and average elasticity to hype of competition of 0.18. Boundless is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -1.47%. %. The volatility of related hype on Boundless Bio, is about 4300.65%, with the expected price after the next announcement by competition of 9.53. About 40.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Boundless Bio, Common had 1:25 split on the March 31, 2011. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Boundless Bio, Basic Forecasting Models to cross-verify your projections.Boundless Bio, Related Hype Analysis
Having access to credible news sources related to Boundless Bio,'s direct competition is more important than ever and may enhance your ability to predict Boundless Bio,'s future price movements. Getting to know how Boundless Bio,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Boundless Bio, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ENGN | enGene Holdings Common | 0.39 | 5 per month | 2.83 | 0.11 | 5.04 | (5.94) | 126.51 | |
| EPRX | Eupraxia Pharmaceuticals Common | 0.00 | 0 per month | 0.00 | (0.06) | 6.77 | (5.99) | 15.88 | |
| CELUW | Celularity | 0.0003 | 6 per month | 15.46 | 0.14 | 37.25 | (28.31) | 139.08 | |
| EXAI | Exscientia Ltd ADR | (0.28) | 9 per month | 0.00 | (0.01) | 10.93 | (7.82) | 33.70 | |
| EXEL | Exelixis | 0.27 | 12 per month | 2.20 | (0.01) | 1.84 | (1.99) | 10.48 | |
| EYEN | Eyenovia | (0.17) | 9 per month | 0.00 | (0.09) | 12.70 | (15.07) | 40.04 | |
| EYPT | Eyepoint Pharmaceuticals | 0.94 | 10 per month | 0.00 | (0.09) | 5.66 | (6.26) | 24.41 | |
| FATE | Fate Therapeutics | (0.04) | 10 per month | 0.00 | (0.07) | 9.74 | (8.53) | 26.19 | |
| FBIO | Fortress Biotech | (0.02) | 9 per month | 0.00 | (0.02) | 10.10 | (7.03) | 24.66 |
Boundless Bio, Additional Predictive Modules
Most predictive techniques to examine Boundless price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Boundless using various technical indicators. When you analyze Boundless charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Boundless Bio, Predictive Indicators
The successful prediction of Boundless Bio, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Boundless Bio, Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Boundless Bio, based on analysis of Boundless Bio, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Boundless Bio,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Boundless Bio,'s related companies. | 2023 | 2024 (projected) | Net Debt To EBITDA | 0.4 | 0.73 | Intangibles To Total Assets | 0.0283 | 0.0269 |
Story Coverage note for Boundless Bio,
The number of cover stories for Boundless Bio, depends on current market conditions and Boundless Bio,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Boundless Bio, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Boundless Bio,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Boundless Bio, Short Properties
Boundless Bio,'s future price predictability will typically decrease when Boundless Bio,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Boundless Bio, Common often depends not only on the future outlook of the potential Boundless Bio,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Boundless Bio,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.2 M | |
| Cash And Short Term Investments | 120.8 M |
Check out Boundless Bio, Basic Forecasting Models to cross-verify your projections. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Boundless Bio,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.33) | Return On Equity (0.53) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.